EcoDrugPlus

Ensembl ID : ENSAMXG00000030131
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSAMXG00000007726
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSAMXG00000002471
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSAMXG00000000882
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSAMXG00000035094
Gene Symbol: -
Cross references: -
241 Possible Orthologues:

Ensembl ID : ENSAMXG00000035087
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSAMXG00000006849
Gene Symbol: RXRAA
1 Cross references
220 Possible Orthologues:

Ensembl ID : ENSAMXG00000016808
Gene Symbol: TTK
1 Cross references
205 Possible Orthologues:

Ensembl ID : ENSAMXG00000030766
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSAMXG00000011882
Gene Symbol: -
Cross references: -
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).